MANAGING COMPLEX CONDITIONS
Specialty drug costs are on a meteoric rise, now exceeding 55% of total drug spend.1 What’s more, 35% of total drug spend is driven by medical drug spend.2 Integrated solutions and strategies – across both medical and pharmacy benefits – help you successfully navigate the complicated and evolving specialty landscape.
MEDDRIVE™
Insights, resources and consultation to help reduce medical drug costs
Florida Blue + Prime combines our collective knowledge and the power of integration to help you control rising medical drug costs. Using enhanced medical drug tools – including biosimilars, medical rebates and low net cost savings – we help you develop and implement a comprehensive solution to realize potential savings. Biologic drugs are changing lives for the people who need them – but often at a very high cost. Florida Blue + Prime promotes the use of evidence-based biosimilar drugs that may cost up to 35% less while delivering the same outcomes.3
Florida Blue contracts with Prime Therapeutics, LLC to provide pharmacy benefit management and home delivery pharmacy services.
Health insurance is offered by Blue Cross and Blue Shield of Florida, Inc., DBA Florida Blue.
1 IQVIA Institute for Human Data Science. (2022, April). The use of medicines in the U.S. 2022. https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/the-use-of-medicines-in-the-us-2022/iqvia-institute-the-use-of-medicines-in-the-us-2022.pdf
2 Pharmaceutical Strategies Group, LLC. (2022). 2022 Artemetrx® state of specialty spend and trend report. https://www.psgconsults.com/specialtyreport2022
3 Biologic Medicines: The Biggest Driver of Rising Drug Prices. (2019, March 8). Forbes. https://www.forbes.com/sites/theapothecary/2019/03/08/biologic-medicines-the-biggest-driver-of-rising-drug-prices/?sh=37c36b0718b0